If You Are Affiliated With This Page And Would Like It Removed Please Contact Pressreleases@franklyinc.com Source Financialbuzz.com New York, March 14, 2017 /prnewswire/ — Financialbuzz.com News Commentary According To Arcview Market Research, The Regulated Cannabis Sales In North America Totaled $6.9 Billion In 2016, Which Is A 30 Percent Increase From 2015.

If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE FinancialBuzz.com NEW YORK, March 14, 2017 /PRNewswire/ — FinancialBuzz.com News Commentary According Marijuana Stocks to Arcview Market Research, the regulated cannabis sales in North America totaled $6.9 billion in 2016, which is a 30 percent increase from 2015. Sales are projected to increase to $21.6 billion by the year 2021, representing a 26 percent compound annual growth rate. The data also points out that if sales from the illegal markets are included in the calculations, then cannabis consumers in the United States and Canada spent over $53 billion in 2016. The difference in these sales figures indicate the potential strength if the legalization process and decriminalization of cannabis continues. CURE Pharmaceutical Holding Corp. (OTC: CURR), Axim Biotechnologies Inc. (OTC: AXIM), General Cannabis Corporation (OTC: CANN), Cannabis Sativa Inc. (OTC: CBDS), Medicine Man Technologies Inc. (OTC: MDCL) Troy Dayton, CEO of Arcview Market Research said in a statement, “The enormous amount of existing, if illicit, consumer spending sets cannabis apart from most other major consumer-market investment opportunities throughout history; the cannabis industry doesn’t need to create demand for a new product or innovation – it just needs to move demand for an already widely-popular product into legal channels.” CURE Pharmaceutical Holding Corp.

To read more visit http://www.wfmj.com/story/34803726/the-growth-in-legal-cannabis-market-sales

Comments are closed.